Aspen Neuroscience files for IPO to advance Parkinson's cell therapy
Aspen Neuroscience, aiming to be the first U.S. public company focused on a Parkinson's cell therapy, has filed to list on Nasdaq.
Clinical AI, drug discovery, devices, and regulatory approvals.
Aspen Neuroscience, aiming to be the first U.S. public company focused on a Parkinson's cell therapy, has filed to list on Nasdaq.
A meta-analysis finds that patient navigation and reminder systems increase colonoscopy completion after positive stool-based screening, though rates still fall short of the 80% target.
A University of Texas at Austin study finds that even brief daily exercise may increase restorative deep sleep.
An Italian registry study reports high remission rates and steroid-sparing benefits for avacopan, offering real-world evidence as the drug faces safety and data-integrity questions.
A case report shows how an unregulated joint pain supplement containing undeclared dexamethasone led to iatrogenic Cushing's syndrome in a middle-aged man.
A phase III trial found the investigational pan-amyloid tracer 124I-evuzamitide detected cardiac amyloidosis with high sensitivity and outperformed bone scintigraphy in early ATTR cases.
A Dallas conference will examine how consumer-centered care is influencing healthcare across diagnostics, employer benefits, and other sectors.
A roundup covering Bausch + Lomb's CEO switch, Merck's remigromig safety data, and Tezspire's Phase 3 win in eosinophilic esophagitis.
A microvascular imaging marker taken immediately after successful thrombectomy predicted infarct growth and poor 90-day outcomes better than standard perfusion measures.
A new argument reframes the lack of pediatric devices and drugs as a misaligned incentive problem rather than a small-market issue.
A bimatoprost-eluting intraocular lens reduced intraocular pressure as effectively as standard IOL plus timolol drops in a 12-month randomized trial.
A MedPage Today roundup reports on lawsuits, criminal charges, and civil judgments across hospitals and physicians.
The Constitutional Court's ruling restores a ban on minor patent tweaks, a win for patient advocates seeking broader drug access.
A mouse study suggests that eating fat before carbohydrates slows digestion and triggers a hormone-nerve response that limits blood sugar spikes.
Texas A&M researchers find that polyethylene microplastics may promote fatty liver disease, with Western-style diets worsening the effect.
A MedCity News essay argues that patient recordings are the next step in healthcare accountability, building on the OpenNotes movement.
Strengthening daily rhythms helped mice recover after stroke by boosting the brain's waste clearance and reducing inflammation, even when treatment began days later.
The cryoablation device maker is shrinking sharply while it weighs strategic alternatives ahead of a likely Nasdaq delisting.